JFG
TCRX icon

Jefferies Financial Group’s TScan Therapeutics TCRX Stock Holding History

Jefferies Financial Group’s Portfolio TCRX Stock Details TCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,200
Closed -$96.9K – 1465
2024
Q1 		$96.9K Buy
+12,200
New +$96.9K ﹤0.01% 1121